73 related articles for article (PubMed ID: 16832755)
1. Beta-cyclodextrin-enhanced solubilization of phenylsulfonyl carboxylates in water.
Liu X; Hou J; Wang L; Luo W; Cui B
Bull Environ Contam Toxicol; 2006 Jul; 77(1):51-9. PubMed ID: 16832755
[No Abstract] [Full Text] [Related]
2. Influence of cyclodextrin complexation on the Vibrio fischeri toxicity of phenylsulfonyl carboxylates.
Liu XH; Hou J; Wang L; Luo WR; Cui BS
J Environ Sci Health A Tox Hazard Subst Environ Eng; 2007 Feb; 42(2):149-53. PubMed ID: 17182385
[TBL] [Abstract][Full Text] [Related]
3. QSPR to aqueous solubility (lgSw) of alkyl(1-phenylsulfonyl) cycloalkane-carboxylates using MLSER model and ab initio.
Wang Z; Han X; Zhai Z
Chemosphere; 2006 Jan; 62(3):349-56. PubMed ID: 15990150
[TBL] [Abstract][Full Text] [Related]
4. Mode of action of beta-cyclodextrin as an absorption enhancer of the water-soluble drug meglumine antimoniate.
Martins PS; Ochoa R; Pimenta AM; Ferreira LA; Melo AL; da Silva JB; Sinisterra RD; Demicheli C; Frézard F
Int J Pharm; 2006 Nov; 325(1-2):39-47. PubMed ID: 16876345
[TBL] [Abstract][Full Text] [Related]
5. Effects of hydroxypropyl-beta-cyclodextrin on the chemical stability and the aqueous solubility of thalidomide enantiomers.
Alvarez C; Calero J; Menéndez JC; Torrado S; Torrado JJ
Pharmazie; 2008 Jul; 63(7):511-3. PubMed ID: 18717484
[TBL] [Abstract][Full Text] [Related]
6. Molecular encapsulation of thalidomide with sulfobutyl ether-7 beta-cyclodextrin for immediate release property: enhanced in vivo antitumor and antiangiogenesis efficacy in mice.
Kale R; Tayade P; Saraf M; Juvekar A
Drug Dev Ind Pharm; 2008 Feb; 34(2):149-56. PubMed ID: 18302033
[TBL] [Abstract][Full Text] [Related]
7. Cyclodextrins as pharmaceutical solubilizers.
Brewster ME; Loftsson T
Adv Drug Deliv Rev; 2007 Jul; 59(7):645-66. PubMed ID: 17601630
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of water-solubility and bioactivity of paclitaxel using modified cyclodextrins.
Hamada H; Ishihara K; Masuoka N; Mikuni K; Nakajima N
J Biosci Bioeng; 2006 Oct; 102(4):369-71. PubMed ID: 17116587
[TBL] [Abstract][Full Text] [Related]
9. Preparation of amorphous indomethacin from aqueous 2,6-di-O-methyl-beta-cyclodextrin solution.
Iohara D; Hirayama F; Ishiguro T; Arima H; Uekama K
Int J Pharm; 2008 Apr; 354(1-2):70-6. PubMed ID: 18093762
[TBL] [Abstract][Full Text] [Related]
10. Suppression of estrogenic activity of 17-beta-estradiol by beta-cyclodextrin.
Oishi K; Toyao K; Kawano Y
Chemosphere; 2008 Dec; 73(11):1788-92. PubMed ID: 18840390
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological in vivo test to evaluate the bioavailability of some St John's Wort innovative oral preparations.
Isacchi B; Galeotti N; Bergonzi MC; Ghelardini C; Bilia AR; Vincieri FF
Phytother Res; 2009 Feb; 23(2):197-205. PubMed ID: 18696747
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and pharmacological evaluation of a new targeted drug carrier system: beta-cyclodextrin coupled to oxytocin.
Bertolla C; Rolin S; Evrard B; Pochet L; Masereel B
Bioorg Med Chem Lett; 2008 Mar; 18(6):1855-8. PubMed ID: 18296049
[TBL] [Abstract][Full Text] [Related]
13. Inclusion complexes of bisphenol A with cyclomaltoheptaose (beta-cyclodextrin): solubilization and structure.
Yang ZX; Chen Y; Liu Y
Carbohydr Res; 2008 Sep; 343(14):2439-42. PubMed ID: 18653172
[TBL] [Abstract][Full Text] [Related]
14. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems.
Onyeji CO; Omoruyi SI; Oladimeji FA
Pharmazie; 2007 Nov; 62(11):858-63. PubMed ID: 18065103
[TBL] [Abstract][Full Text] [Related]
15. Comparative interaction of 2-hydroxypropyl-beta-cyclodextrin and sulfobutylether-beta-cyclodextrin with itraconazole: phase-solubility behavior and stabilization of supersaturated drug solutions.
Brewster ME; Vandecruys R; Peeters J; Neeskens P; Verreck G; Loftsson T
Eur J Pharm Sci; 2008 Jul; 34(2-3):94-103. PubMed ID: 18420390
[TBL] [Abstract][Full Text] [Related]
16. Estradiol sustained release from high affinity cyclodextrin hydrogels.
Rodriguez-Tenreiro C; Alvarez-Lorenzo C; Rodriguez-Perez A; Concheiro A; Torres-Labandeira JJ
Eur J Pharm Biopharm; 2007 Apr; 66(1):55-62. PubMed ID: 17081737
[TBL] [Abstract][Full Text] [Related]
17. Interaction between nitroheterocyclic compounds with beta-cyclodextrins: phase solubility and HPLC studies.
de Melo NF; Grillo R; Rosa AH; Fraceto LF
J Pharm Biomed Anal; 2008 Aug; 47(4-5):865-9. PubMed ID: 18534804
[TBL] [Abstract][Full Text] [Related]
18. Complexation of morin with three kinds of cyclodextrin. A thermodynamic and reactivity study.
Jullian C; Orosteguis T; Pérez-Cruz F; Sánchez P; Mendizabal F; Olea-Azar C
Spectrochim Acta A Mol Biomol Spectrosc; 2008 Nov; 71(1):269-75. PubMed ID: 18262835
[TBL] [Abstract][Full Text] [Related]
19. A best comprehension about the toxicity of phenylsulfonyl carboxylates in Vibrio fischeri using quantitative structure activity/property relationship methods.
de Melo EB; Martins JP; Miranda EH; Ferreira MM
J Hazard Mater; 2016 Mar; 304():233-41. PubMed ID: 26551227
[TBL] [Abstract][Full Text] [Related]
20. Kinetic study for the inclusion complex of carboxylic acids with cyclodextrin by the ultrasonic relaxation method.
Nishikawa S; Kondo M
J Phys Chem B; 2006 Dec; 110(51):26143-7. PubMed ID: 17181269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
